S. Beslija
- Oncology top 10%
- Obstetrics and Gynecology top 2%
- Surgery
- Epidemiology
- Cancer Research top 10%
- Co-authors
- Juan Carlos AlcedoHelen BarracloughMauro OrlandoJuan José ZarbáShahid HameedPittayapoom PattaranutapornJulie M. BlairLuís Casanova
- Topics
- Cancer Treatment and Pharmacology (24 papers)Advanced Breast Cancer Therapies (13 papers)Breast Cancer Treatment Studies (13 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Research
- Partner nations
- Bosnia and HerzegovinaAustriaHungary
In The Last Decade
S. Beslija
45 papers receiving 856 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 430
- Obstetrics and Gynecology 343
- Surgery 237
- Epidemiology 196
- Cancer Research 182
Countries citing papers authored by S. Beslija
This map shows the geographic impact of S. Beslija's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Beslija with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Beslija more than expected).
Fields of papers citing papers by S. Beslija
This network shows the impact of papers produced by S. Beslija. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Beslija. The network helps show where S. Beslija may publish in the future.
Co-authorship network of co-authors of S. Beslija
This figure shows the co-authorship network connecting the top 25 collaborators of S. Beslija. A scholar is included among the top collaborators of S. Beslija based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Beslija. S. Beslija is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 47 | |
| 6 | 4 | |
| 7 | 11 | |
| 8 | 42 | |
| 9 | 21 | |
| 10 | 24 | |
| 11 | 60 | |
| 12 | 4 | |
| 13 | 16 | |
| 14 | Randomized phase II study of induction chemotherapy with gemcitabine plus cisplatin followed by sequential radiotherapy versus radiotherapy alone in patients with stage III non-small cell lung cancer. | 0 |
| 15 | Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervixbreakdown → | 349 |
| 16 | 11 | |
| 17 | 1 | |
| 18 | How to make the best use of limited resources in breast cancer treatment--experiences in Bosnia & Herzegovina. | 4 |
| 19 | 25 | |
| 20 | 16 |
About S. Beslija
S. Beslija is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 876 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (24 papers), Advanced Breast Cancer Therapies (13 papers) and Breast Cancer Treatment Studies (13 papers). The work is most often cited by research in Obstetrics and Gynecology (343 citations), Reproductive Medicine (149 citations) and Oncology (430 citations). S. Beslija has collaborated with scholars based in Bosnia and Herzegovina, Austria and Hungary. Frequent co-authors include Juan Carlos Alcedo, Helen Barraclough, Mauro Orlando, Juan José Zarbá, Shahid Hameed, Pittayapoom Pattaranutaporn, Julie M. Blair, Luís Casanova, Alfonso Dueñas‐González and Firuza D. Patel. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.